Načítá se...
Evolving Therapeutic Strategies for the Classic Philadelphia-Negative Myeloproliferative Neoplasms
Despite the emergence of JAK inhibitors, there is a need for disease-modifying treatments for Philadelphia-negative myeloproliferative neoplasms (MPNs). JAK inhibitors ameliorate symptoms and address splenomegaly, but because of the heterogeneous contributors to the disease process, JAK inhibitor mo...
Uloženo v:
| Vydáno v: | EBioMedicine |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4739416/ https://ncbi.nlm.nih.gov/pubmed/26870834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2016.01.010 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|